PATENT CLAIM ANALYSIS

Application Number: 15927636
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "510000"]

Abstract:
The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

Claim (Index 36):
The method of  claim 35 , wherein both \u2014OR 1  and \u2014OR 2  are derivatized with the same moiety.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15617243', '14742544', '15178637', '15473434', '14829180']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7844208933102793
- 35 USC 102 Novelty (BERT): 0.5018655795089076
- Combined Prediction Score: 0.7561653619301422
- Mean Citation Score: 244.71725
- Max Citation Score: 251.23091
- Similarity Product: 181.9655964996421

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test